Yoshida M, Hanashi T, Momma K, Yamada Y, Sakaki N, Koike M, Takizawa T, Kawamura T
Dept. of Surgery, Tokyo Metropolitan Komagome General Hospital.
Gan To Kagaku Ryoho. 1995 Jun;22(7):847-54.
Clinico-pathological results of patients with superficial esophageal cancer was reviewed to determine the indications of endoscopic mucosal resection (EMR) for esophageal cancer as a radical treatment and to evaluate clinical results of EMR. The analysis on eighty-seven cases with superficial esophageal cancer who underwent esophagectomy revealed no lymph node metastasis in any 0% of case with cancer confined to the lamina propria mucosae, 10% of cancer reaching the muscularis mucosae and 43% of cancer infiltrating the submucosa. These results suggested that the endoscopic mucosal resection should be indicated for patients with esophageal cancer confined to the lamina propria mucosae. The accuracy rate for estimating depth of invasion of mucosal cancer of the esophagus was 96%. We early established "the double channel technique" for resection of mucosal lesion of the esophagus with a major part of the submucosa, we used it for sixty-nine cases, and all were eventually discharged. Immediate complications of EMR were noted in 12.9% of all cases (mediastinal emphysema: 2.9%, ulcer bleeding: 10%) and the late complication in 7.2% (esophageal stricture due to scar formation: 5.8% and ulcer bleeding 5 days after EMR: 1.4%). All cases who developed stricture had mucosal defect over 3/4 the circumference. The cumulative 5-year survival rate of patients with esophageal mucosal cancer treated by EMR (86%) showed no significant difference from those treated by esophagectomy (83.2%). We to conclude that endoscopic mucosal resection is indicated for the patient with mucosal cancer confined to the lamina propria mucosae. One can expect an excellent prognosis by less invasive treatment than esophagectomy.
回顾浅表性食管癌患者的临床病理结果,以确定内镜黏膜切除术(EMR)作为食管癌根治性治疗的适应证,并评估EMR的临床效果。对87例行食管切除术的浅表性食管癌患者进行分析,结果显示,癌局限于黏膜固有层的病例无淋巴结转移(0%),癌侵及黏膜肌层的病例有10%发生淋巴结转移,癌浸润至黏膜下层的病例有43%发生淋巴结转移。这些结果提示,EMR适用于癌局限于黏膜固有层的食管癌患者。食管黏膜癌浸润深度的估计准确率为96%。我们早期建立了“双通道技术”用于切除食管黏膜病变及大部分黏膜下层,应用于69例患者,所有患者最终均出院。EMR的即刻并发症发生率为12.9%(纵隔气肿:2.9%,溃疡出血:10%),晚期并发症发生率为7.2%(瘢痕形成导致的食管狭窄:5.8%,EMR后5天溃疡出血:1.4%)。所有发生狭窄的病例黏膜缺损均超过周长的3/4。EMR治疗的食管黏膜癌患者的5年累积生存率(86%)与食管切除术治疗的患者(83.2%)无显著差异。我们得出结论,EMR适用于癌局限于黏膜固有层的患者。与食管切除术相比,采用侵入性较小的治疗方法有望获得良好的预后。